Search results
Results from the WOW.Com Content Network
The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population (and ...
4 January: Eligible individuals of all age groups can walk into any vaccination centre without booking an appointment. [4]9 January: In the wake of China's reopening, Health Minister Ong Ye Kung announced that travelers from China to Singapore would not be required to undergo pre-departure COVID-19 testing.
Singapore had relatively few COVID-19 cases before the emergence of the Delta and Omicron variants from 8 May 2021 to 29 March 2022. [2] With its relative success in curbing the early spread of the virus in Singapore, the term "circuit breaker" and its measures was subsequently adopted by other countries, particularly in Canada and the United ...
A COVID-19 vaccine is intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 . Prior to the COVID-19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute ...
For more on COVID-19: Public health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading. New COVID vaccines are here. What to know ...
The COVID-19 pandemic in Singapore was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 . The first case in Singapore was confirmed on 23 January 2020. Early cases were primarily imported until local transmission began to develop in February and March.
In August, China's National Intellectual Property Administration issued the country's first COVID-19 vaccine patent to CanSino. [34] On 16 May 2020, Canadian Prime Minister Justin Trudeau announced Health Canada had approved Phase II trials to be conducted by the Canadian Center for Vaccinology (CCfV) on the COVID-19 vaccine produced by CanSino.
"While Covid-19 remains a concern we are seeing fewer hospitalizations and Covid-related deaths as compared to last year — likely a result of widespread vaccination and prior infection," a CDC ...